Wednesday, December 1, 2021

Sputnik V

Dr Reddy’s to launch Sputnik V under EUA by March

The bridging phase II and phase III study on 1,600 subjects in India is assessing immunogenicity and safety.

Pakistan approves emergency use of Sputnik V COVID-19 vaccine

Sputnik V is the third vaccine to be approved for the emergency use in the country, the report said.

Dr Reddy’s gets DCGI nod for phase 3 trial for Sputnik V vaccine

The trial will be conducted on 1,500 subjects as part of the randomised, double-blind, parallel-group, placebo-controlled study in India

India to produce 300 million doses of Sputnik V vaccine

Sputnik V, the world's first COVID-19 vaccine, is over 95 per cent effective, said Russian President Vladimir Putin on Thursday.

No alcohol for 2 months after Covid vaccine, experts tell why

According to the experts, warning against alcohol consumption that has been issued is a general immune-boosting measure rather than as a specific contraindication or interaction with the vaccine.

No alcohol for 2 months after Covid vax, experts tell why

According to the experts, warning against alcohol consumption that has been issued is a general immune-boosting measure rather than as a specific contraindication or interaction with the vaccine.

Britain starts virus jabs as Biden vows 100 million vaccinations

The Pfizer-BioNTech jab is one of several vaccines bringing hope for an end to the pandemic that has killed more than 1.5 million people worldwide and ravaged economies.

Russia to produce Sputnik V Covid vaccine in India

According to the RDIF -- Russia's sovereign wealth fund, the vaccine's interim clinical trial results show 95 per cent efficacy on the 42nd day after the first dose.

Tipping point

Developments on vaccine front offer a tentative timeline on when it could be available on a mass scale

Russian vaccine arrives in India for human clinical trial

The vaccine supplies for the global market will be produced by RDIF's international partners in India, Brazil, China, South Korea and other countries.

Dr Reddy’s partners with BIRAC for Sputnik V vaccine trials in India

Collaboration will allow Dr Reddy’s to identify and use some of the Biotechnology Industry Research Assistance Council’s clinical trial centres

Dr Reddy’s, RDIF receive approval to conduct clinical trial for Sputnik V vaccine

This will be a multi-centre and randomised controlled study, which will include safety and immunogenicity study, Dr Reddy’s said in a statement.

Latest News

- Advertisement -